Bringing Transformative Oncology Therapies
Compass Therapeutics (compasstherapeutics.com) scores 69 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, in the 21st percentile of 19793 Healthcare brands.
Compass Therapeutics is a biopharmaceutical company headquartered in Boston, Massachusetts, founded in 2014. The company focuses on discovering and developing innovative oncology therapies, using proprietary discovery platforms to identify therapeutic leads that connect the innate and adaptive immune system. Its mission centers on bringing transformative cancer treatments to patients, positioning itself as an immuno-oncology innovator that collaborates with oncologists, clinical researchers, and biopharmaceutical partners to advance a pipeline of novel cancer treatment candidates.
| Brand Name | Compass Therapeutics |
|---|---|
| Domain | compasstherapeutics.com |
| Industry | Healthcare |
| Founded | 2014 |
| Headquarters | Boston, United States |
| Main Competitors | MacroGenics (74/100), Zymeworks, Agenus (82/100), Compugen (82/100), Seagen (84/100) |
Moz Domain Authority 35/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #3,467,441 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "To bring transformative oncology therapies to patients by discovering and developing innovative cancer treatments." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, X (Twitter), Instagram; no detected presence on Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Compass Therapeutics?", Claude could identify the brand as of October 2026. Compass Therapeutics is a clinical-stage biopharmaceutical company based in Boston that develops novel antibody-based therapeutics for cancer, focusing on targets in the tumor microenvironment to boost immune response against tumors. Best known for Developing multi-specific antibody drug candidates for oncology, including its CTX-009 (bispecific DLL4/VEGF-A) and CTX-471 (CD137 agonist) programs.
When asked "Best brands similar to Compass Therapeutics?", Claude would recommend Compass Therapeutics as of October 2026. It's a legitimate, publicly traded clinical-stage oncology biotech with a distinct antibody pipeline, so it fits if someone asks about emerging cancer immunotherapy companies.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Compass Therapeutics's main competitors in Healthcare: MacroGenics (74/100), Agenus (82/100), Compugen (82/100), Seagen (84/100).
Sources: Brand Analyzer scan
Compass Therapeutics has limited AI-search visibility, scoring 27/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 19, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Compass Therapeutics official site
Compass Therapeutics was founded in 2014. Compass Therapeutics operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Compass Therapeutics scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Compass Therapeutics official site
Compass Therapeutics is a biopharmaceutical company based in Boston, Massachusetts, founded in 2014. It specializes in discovering and developing innovative oncology therapies aimed at bringing transformative cancer treatments to patients.
Sources: Compass Therapeutics official site
Compass Therapeutics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Compass Therapeutics official site
Compass Therapeutics discovers and develops cancer treatments by leveraging proprietary discovery platforms. The company advances a portfolio of therapeutic candidates designed to bridge the innate and adaptive immune system, aiming to address unmet needs in oncology care.
Sources: Compass Therapeutics official site
Compass Therapeutics' work is intended for cancer patients, oncologists, clinical researchers, and biopharmaceutical industry partners who are seeking novel immuno-oncology treatments and collaborations in cancer drug development.
Sources: Compass Therapeutics official site
Compass Therapeutics scores 27/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Compass Therapeutics has a weak AI-visibility profile at 27/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (48/100) and its weakest is trust (19/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #3,467,441 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 35/100 and thin schema.org structured data. In a live check, Claude could already identify Compass Therapeutics from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Compass Therapeutics: Combi-Blocks (69/100), Cochrane Library (69/100), Complete Podiatry (69/100), Compumedics (69/100).
A step up - brands to learn from: Zentralwohlfahrtsstelle der Juden in Deutschland e.V. (71/100), ZT Corporate (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.